Selected research
Industry Research
Oral Proteins and Peptides Industry Research Report 2026
Market perspective
The global Oral Proteins and Peptides market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral Proteins and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral Proteins and Peptides is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral Proteins and Peptides is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral Proteins and Peptides include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma (Amryt Pharma), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral Proteins and Peptides market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral Proteins and Peptides Market by Company
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma (Amryt Pharma)
Oral Proteins and Peptides Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Oral Proteins and Peptides Segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders
Oral Proteins and Peptides Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Proteins and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Proteins and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Proteins and Peptides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral Proteins and Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Linaclotide
- Insulin
- Plecanatide
- Cyclosporine
- Octreotide
Applications
- Gastric & Digestive Disorders
- Bone Diseases
- Diabetes
- Hormonal Disorders
Companies covered
- Ironwood & Allergan
- Novo Nordisk
- Synergy Pharmaceuticals （Salix）
- Novartis
- Chiasma (Amryt Pharma)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral Proteins and Peptides Market Size (2021-2032)
- 2.2.2 Global Oral Proteins and Peptides Sales (2021-2032)
- 2.2.3 Global Oral Proteins and Peptides Market Average Price (2021-2032)
- 2.3 Oral Proteins and Peptides by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Linaclotide
- 2.3.3 Insulin
- 2.3.4 Plecanatide
- 2.3.5 Cyclosporine
- 2.3.6 Octreotide
- 2.4 Oral Proteins and Peptides by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Gastric & Digestive Disorders
- 2.4.3 Bone Diseases
- 2.4.4 Diabetes
- 2.4.5 Hormonal Disorders
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral Proteins and Peptides Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral Proteins and Peptides Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Oral Proteins and Peptides Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral Proteins and Peptides Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral Proteins and Peptides Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral Proteins and Peptides, Product Type & Application
- 3.8 Global Manufacturers of Oral Proteins and Peptides, Established Date
- 3.9 Global Oral Proteins and Peptides Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ironwood & Allergan
- 4.1.1 Ironwood & Allergan Company Information
- 4.1.2 Ironwood & Allergan Business Overview
- 4.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
- 4.1.5 Ironwood & Allergan Recent Developments
- 4.2 Novo Nordisk
- 4.2.1 Novo Nordisk Company Information
- 4.2.2 Novo Nordisk Business Overview
- 4.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
- 4.2.5 Novo Nordisk Recent Developments
- 4.3 Synergy Pharmaceuticals （Salix）
- 4.3.1 Synergy Pharmaceuticals （Salix） Company Information
- 4.3.2 Synergy Pharmaceuticals （Salix） Business Overview
- 4.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
- 4.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Oral Proteins and Peptides Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Chiasma (Amryt Pharma)
- 4.5.1 Chiasma (Amryt Pharma) Company Information
- 4.5.2 Chiasma (Amryt Pharma) Business Overview
- 4.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
- 4.5.5 Chiasma (Amryt Pharma) Recent Developments
5 Global Oral Proteins and Peptides Market Scenario by Region
- 5.1 Global Oral Proteins and Peptides Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral Proteins and Peptides Sales by Region: 2021-2032
- 5.2.1 Global Oral Proteins and Peptides Sales by Region: 2021-2026
- 5.2.2 Global Oral Proteins and Peptides Sales by Region: 2027-2032
- 5.3 Global Oral Proteins and Peptides Revenue by Region: 2021-2032
- 5.3.1 Global Oral Proteins and Peptides Revenue by Region: 2021-2026
- 5.3.2 Global Oral Proteins and Peptides Revenue by Region: 2027-2032
- 5.4 North America Oral Proteins and Peptides Market Facts & Figures by Country
- 5.4.1 North America Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral Proteins and Peptides Sales by Country (2021-2032)
- 5.4.3 North America Oral Proteins and Peptides Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oral Proteins and Peptides Market Facts & Figures by Country
- 5.5.1 Europe Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral Proteins and Peptides Sales by Country (2021-2032)
- 5.5.3 Europe Oral Proteins and Peptides Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral Proteins and Peptides Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral Proteins and Peptides Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral Proteins and Peptides Market Facts & Figures by Country
- 5.7.1 South America Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral Proteins and Peptides Sales by Country (2021-2032)
- 5.7.3 South America Oral Proteins and Peptides Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oral Proteins and Peptides Sales by Type (2021-2032)
- 6.1.1 Global Oral Proteins and Peptides Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Oral Proteins and Peptides Sales Market Share by Type (2021-2032)
- 6.2 Global Oral Proteins and Peptides Revenue by Type (2021-2032)
- 6.2.1 Global Oral Proteins and Peptides Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral Proteins and Peptides Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral Proteins and Peptides Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral Proteins and Peptides Sales by Application (2021-2032)
- 7.1.1 Global Oral Proteins and Peptides Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Oral Proteins and Peptides Sales Market Share by Application (2021-2032)
- 7.2 Global Oral Proteins and Peptides Revenue by Application (2021-2032)
- 7.2.1 Global Oral Proteins and Peptides Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral Proteins and Peptides Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral Proteins and Peptides Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral Proteins and Peptides Value Chain Analysis
- 8.1.1 Oral Proteins and Peptides Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral Proteins and Peptides Production Mode & Process
- 8.2 Oral Proteins and Peptides Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral Proteins and Peptides Distributors
- 8.2.3 Oral Proteins and Peptides Customers
9 Global Oral Proteins and Peptides Analyzing Market Dynamics
- 9.1 Oral Proteins and Peptides Industry Trends
- 9.2 Oral Proteins and Peptides Industry Drivers
- 9.3 Oral Proteins and Peptides Industry Opportunities and Challenges
- 9.4 Oral Proteins and Peptides Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst